Cipher Pharmaceuticals Stock Target Price
CPHRFDelisted Stock | USD 2.57 0.00 0.00% |
Cipher Pharmaceuticals fundamentals help investors to digest information that contributes to Cipher Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Cipher OTC Stock. The fundamental analysis module provides a way to measure Cipher Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cipher Pharmaceuticals otc stock.
Cipher |
Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
All Next | Launch Module |
Cipher Fundamentals
Return On Equity | 0.24 | ||||
Return On Asset | 0.15 | ||||
Profit Margin | 0.45 % | ||||
Operating Margin | 0.57 % | ||||
Current Valuation | 46.13 M | ||||
Shares Outstanding | 25.12 M | ||||
Shares Owned By Insiders | 44.12 % | ||||
Number Of Shares Shorted | 11.43 K | ||||
Price To Earning | 15.54 X | ||||
Price To Book | 1.63 X | ||||
Price To Sales | 3.28 X | ||||
Revenue | 21.94 M | ||||
Gross Profit | 18.26 M | ||||
EBITDA | 11.85 M | ||||
Net Income | 7.76 M | ||||
Cash And Equivalents | 24.19 M | ||||
Cash Per Share | 0.96 X | ||||
Total Debt | 507 K | ||||
Debt To Equity | 0.01 % | ||||
Current Ratio | 2.51 X | ||||
Book Value Per Share | 1.77 X | ||||
Cash Flow From Operations | 13.81 M | ||||
Short Ratio | 0.97 X | ||||
Earnings Per Share | 0.36 X | ||||
Target Price | 5.59 | ||||
Number Of Employees | 26 | ||||
Beta | 1.03 | ||||
Market Capitalization | 64.32 M | ||||
Total Asset | 51.65 M | ||||
Z Score | 75.6 | ||||
Net Asset | 51.65 M |
About Cipher Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cipher Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cipher Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cipher Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Cipher OTC Stock
If you are still planning to invest in Cipher Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cipher Pharmaceuticals' history and understand the potential risks before investing.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Global Correlations Find global opportunities by holding instruments from different markets |